Cargando…
Systemic IL-12 Administration Alters Hepatic Dendritic Cell Stimulation Capabilities
The liver is an immunologically unique organ containing tolerogenic dendritic cells (DC) that maintain an immunosuppressive microenvironment. Although systemic IL-12 administration can improve responses to tumors, the effects of IL-12-based treatments on DC, in particular hepatic DC, remain incomple...
Autores principales: | Chan, Tim, Back, Timothy C., Subleski, Jeffrey J., Weiss, Jonathan M., Ortaldo, John R., Wiltrout, Robert H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302816/ https://www.ncbi.nlm.nih.gov/pubmed/22428016 http://dx.doi.org/10.1371/journal.pone.0033303 |
Ejemplares similares
-
LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours
por: Scarzello, Anthony J, et al.
Publicado: (2016) -
IL-12 stimulates CTLs to secrete exosomes capable of activating bystander CD8(+) T cells
por: Li, Lei, et al.
Publicado: (2017) -
AAV2/IL-12 gene delivery into dendritic cells (DC) enhances CTL stimulation above other IL-12 applications: Evidence for IL-12 intracrine activity in DC
por: You, Chang-Xuan, et al.
Publicado: (2012) -
NOD Dendritic Cells Stimulated with Lactobacilli Preferentially Produce IL-10 versus IL-12 and Decrease Diabetes Incidence
por: Manirarora, Jean N., et al.
Publicado: (2011) -
Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells
por: Ma, Xiaojing, et al.
Publicado: (2015)